We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$197M
2
AGN
Allergan plc
AGN
+$135M
3
BHC icon
Bausch Health
BHC
+$129M
4
CVS icon
CVS Health
CVS
+$107M
5
MCK icon
McKesson
MCK
+$94.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$286M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$225M
3
GILD icon
Gilead Sciences
GILD
+$86.1M
4
PRGO icon
Perrigo
PRGO
+$79.4M
5
CAH icon
Cardinal Health
CAH
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$37.3M 0.6%
199,600
+199,300
+66,433% +$36.6M
NEE icon
27
NextEra Energy
NEE
$181B
$36.9M 0.6%
1,543,200
+99,200
+7% +$2.25M
AGN
28
DELISTED
Allergan Inc
AGN
$36.8M 0.6%
296,559
-2,351,441
-89% -$286M
TMO icon
29
Thermo Fisher Scientific
TMO
$213B
$34.8M 0.56%
289,234
+189,012
+189% +$22.5M
QCOR
30
DELISTED
QUESTCOR PHARMA INC
QCOR
$34M 0.55%
+523,000
New +$33.4M
DS
31
DELISTED
Drive Shack Inc.
DS
$33.9M 0.55%
6,710,278
-1,585,527
-19% -$8.12M
BSX icon
32
Boston Scientific
BSX
$69.5B
$33.9M 0.55%
2,504,203
+559,042
+29% +$7.34M
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$33.8M 0.55%
+2,238,000
New +$25.3M
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$33M 0.53%
100,100
-666,431
-87% -$225M
RPRX
35
DELISTED
Repros Therapeutics Inc.
RPRX
$32.7M 0.53%
1,840,799
+100
+0% +$1.94K
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.8B
$32.2M 0.52%
2,000,935
-113,495
-5% -$1.94M
AEP icon
37
American Electric Power
AEP
$69.6B
$32.2M 0.52%
635,138
+93,575
+17% +$4.55M
NVDQ
38
DELISTED
Novadaq Technologies Inc.
NVDQ
$31.2M 0.51%
+1,400,000
New +$27.8M
LVNTA
39
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$30.1M 0.49%
940,500
+109,463
+13% +$3.48M
HCA icon
40
HCA Healthcare
HCA
$87.2B
$30.1M 0.49%
573,329
-1,151,491
-67% -$57.3M
VIRX
41
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$29.9M 0.48%
21,556
+1,906
+10% +$2.22M
SU icon
42
Suncor Energy
SU
$79.4B
$29.9M 0.48%
855,110
+686,238
+406% +$22.9M
FWONA icon
43
Liberty Media Series A
FWONA
$22.5B
$29M 0.47%
1,249,963
+118,917
+11% +$2.84M
RVNC
44
DELISTED
Revance Therapeutics, Inc.
RVNC
$28.3M 0.46%
+898,000
New +$28.1M
ICLR icon
45
Icon
ICLR
$12.6B
$28.3M 0.46%
594,361
-224,568
-27% -$10M
PTEN icon
46
Patterson-UTI
PTEN
$3.98B
$27.2M 0.44%
857,523
+615,496
+254% +$17.1M
HNT
47
DELISTED
HEALTH NET INC
HNT
$26.7M 0.43%
785,369
+581,569
+285% +$19.1M
FEIC
48
DELISTED
FEI COMPANY
FEIC
$26M 0.42%
252,608
+142,825
+130% +$14M
JNJ icon
49
Johnson & Johnson
JNJ
$618B
$25.3M 0.41%
258,010
+137,260
+114% +$12.7M
ENZY
50
DELISTED
Enzymotec Ltd
ENZY
$25.1M 0.41%
1,140,000
+450,000
+65% +$11.9M
1
2
3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.